A detailed history of Group One Trading, L.P. transactions in Fulcrum Therapeutics, Inc. stock. As of the latest transaction made, Group One Trading, L.P. holds 59,395 shares of FULC stock, worth $203,724. This represents 0.01% of its overall portfolio holdings.

Number of Shares
59,395
Previous 20,853 184.83%
Holding current value
$203,724
Previous $196,000 87.76%
% of portfolio
0.01%
Previous 0.01%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$5.98 - $9.31 $230,481 - $358,826
38,542 Added 184.83%
59,395 $368,000
Q1 2024

May 10, 2024

BUY
$6.7 - $12.0 $3,309 - $5,928
494 Added 2.43%
20,853 $196,000
Q4 2023

Feb 14, 2024

BUY
$3.18 - $6.86 $43,203 - $93,199
13,586 Added 200.59%
20,359 $137,000
Q3 2023

Nov 09, 2023

BUY
$3.25 - $6.08 $22,012 - $41,179
6,773 New
6,773 $30,000
Q3 2022

Nov 09, 2022

BUY
$4.92 - $9.1 $3,881 - $7,179
789 Added 867.03%
880 $7,000
Q2 2022

Aug 11, 2022

BUY
$4.2 - $24.0 $382 - $2,184
91 New
91 $0
Q4 2021

Feb 11, 2022

SELL
$14.0 - $28.44 $69,622 - $141,432
-4,973 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$7.28 - $30.97 $36,203 - $154,013
4,973 New
4,973 $140,000

Others Institutions Holding FULC

About Fulcrum Therapeutics, Inc.


  • Ticker FULC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,038,900
  • Market Cap $178M
  • Description
  • Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products for improving the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its product candidates are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystro...
More about FULC
Track This Portfolio

Track Group One Trading, L.P. Portfolio

Follow Group One Trading, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.